CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biopharmaceutical company focused on developing therapeutics targeting Toll-Like Receptors (TLR), today announced that it will present at the Cowen and Company 28th Annual Health Care Conference. The Company will discuss its TLR-targeted drug discovery and development programs and provide a general corporate update. The presentation will be delivered on Thursday, March 20, 2008 at 10:15 a.m. (EDT) at the Boston Marriott Copley Place in Boston, MA.
